INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 299 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $448,909 | -21.6% | 14,197 | +1.1% | 0.00% | -50.0% |
| Q2 2023 | $572,434 | +110836.8% | 14,037 | +1.2% | 0.00% | +100.0% |
| Q1 2023 | $516 | +12.2% | 13,872 | +5.3% | 0.00% | 0.0% |
| Q4 2022 | $460 | -99.9% | 13,175 | -2.7% | 0.00% | -66.7% |
| Q3 2022 | $758,000 | -15.2% | 13,539 | -21.6% | 0.00% | -25.0% |
| Q2 2022 | $894,000 | -24.2% | 17,260 | +6.4% | 0.00% | 0.0% |
| Q1 2022 | $1,179,000 | -33.7% | 16,226 | +8.0% | 0.00% | -50.0% |
| Q4 2021 | $1,777,000 | -11.4% | 15,031 | +0.6% | 0.01% | -20.0% |
| Q3 2021 | $2,005,000 | -17.4% | 14,947 | -0.3% | 0.01% | -33.3% |
| Q2 2021 | $2,426,000 | – | 14,985 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,615,321 | $23,697,000 | 41.29% |
| ARK Investment Management | 8,741,432 | $128,237,000 | 3.23% |
| Nikko Asset Management Americas, Inc. | 7,178,520 | $105,309,000 | 1.66% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $1,635,000 | 0.86% |
| Elmwood Wealth Management, Inc. | 64,204 | $942,000 | 0.82% |
| 361 CAPITAL LLC | 94,772 | $1,390,000 | 0.38% |
| Artal Group S.A. | 199,700 | $2,930,000 | 0.11% |
| StoneX Group Inc. | 14,982 | $220,000 | 0.09% |
| Sumitomo Mitsui Trust Holdings, Inc. | 7,178,520 | $105,309,000 | 0.08% |
| PDT Partners, LLC | 85,517 | $1,255,000 | 0.08% |